In search of the gene for progressive epilepsy with mental retardation (EPMR) we identified DLGAP2, the human homolog of the gene encoding the rat PSD-95/SAP90-associated protein-2 (Dlgap2). We extended the transcript in both the 5' and 3' directions and characterised the genomic structure of the approximately 10 kb gene. Sequence comparisons of human DLGAP2 cDNA sequences obtained from human testis and brain cDNA libraries with homologous rat genes suggest alternative splicing in the 5' end of the gene. The 5' coding sequence of the testis cDNA is complete, whereas based on homology with the rat gene 103 bp of coding sequence may still be missing in the 5' end of the DLGAP2 brain transcript. DLGAP2 was excluded as the gene responsible for EPMR.
Progressive epilepsy with mental retardation (EPMR) is an autosomal recessive disorder characterised by normal early development and childhood onset epilepsy followed by mental retardation. 1 Recently, EPMR was recognised as a new subtype of neuronal ceroid lipofuscinoses (NCLs). 2 We previously assigned the EPMR locus to an approximately 700 kb interval on chromosome 8p (Figure 1 ), [3] [4] [5] and constructed a 3412 bp partial cDNA sequence (Genbank AF009204) mapping to this region. 5 Between nucleotides 1259 and 2956 our cDNA sequence was identical to a partial cDNA sequence encoding a human discs large (hDLG) and a postsynaptic density protein 95 kDa (PSD-95)-associated protein-2, DAP2 6 (GenBank AB000275), except for a G to A difference at position 1741 and 42 nucleotides downstream of position 1867 which was present in DAP2 but absent in our sequence. Our cDNA also showed homology to a rat gene (GenBank U67138) encoding the PSD-95/synapse associated protein 90 (SAP90)-associated mRNA-2, Sapap2. 7 According to the HUGO Nomenclature Committee, the DAP/SAPAP/ GKAP family of discs large associated proteins is denoted as DLGAP. In this paper we refer to the human homolog of the rat Sapap2 (Dlgap2) gene as DLGAP2. The DLGAP proteins interact with the PSD-95/SAP90 protein, which in turn interacts with shaker type potassium channels and other molecules and clusters with these at synaptic junctions. [6] [7] [8] PSD-95/SAP90 may play an important role in the organisation of ion channels and signalling molecules in the synaptic junction. Furthermore, as mutations in two potassium channel genes were recently identified underlying human epilepsy, [9] [10] [11] we considered DLGAP2 a good positional candidate for EPMR. The 3412 bp DLGAP2 sequence was first extended at the 3' end by 1.4 kb using rapid extension of cDNA ends (RACE) (primer 5'-GTG GCC TGG CTC ACA CTT GGC TCT-3'; Clontech Marathon Ready Human Fetal Brain cDNA Library). Secondly, a brain specific EST 12 (A004F35) was found to be extended by screening a brain cDNA library (Clontech cat. no. H13002a), by 5' RACE (primer 5'-TGG AAG GTC GGG G-GA TGA GTT G-3'; Clontech Marathon Ready Human Brain cDNA Library), and by incorporating sequences derived from three genomic clones from the EPMR region yielding a 3.2 kb sequence around this EST. Telomeric to the 3412 bp sequence one exon obtained by exon amplification from BAC 140H1 (Figure 1 ) 5 was found homologous to the 5' coding region of the rat Dlgap2 (GenBank U67138). To confirm that this exon belonged to DLGAP2 we screened the Marathon Ready Brain cDNA Library with primers designed from the exon and DLGAP2 (5'-AGA AGC TGG AGA CTT GGT CCA G-3' and 5'CTC AG-C AGG TAG GGC GGC CG-3', nested primers 5'-AGC CGG GCA TCA GCT TTC-3' and 5'-TCG GGC CCG TGG TGC AGG T-3'). A 214 bp fragment bridging the exon to the known cDNA sequence was amplified. Further sequence comparison with the rat Dlgap2 sequence suggested that 103 bp of the 5' coding sequence was still missing from DLGAP2. Of note, this putative missing region was found to reside outside the critical EPMR region (see below and Figure 1 ).
We attempted to isolate the remaining 5' end by screening various RACE and cDNA libraries. Amplification of the Marathon Ready Human Testis cDNA library (Clontech; primer 5'AGT AGC GCT CCT CAT TGA AGT GCT GC-3'; nested primer 5'-TAC TGC GGG TCT AGA TCC TCC TCT G-3') resulted in a cDNA fragment containing a putative translation initiator ATG codon and an in-frame stop codon 5' to it. This ATG observed in the testis cDNA corresponds to the suggested start codon in the four known rat Dlgap genes. However, in the rat Dlgap2 this codon is the second ATG in the open reading frame. 7 As in the human DLGAP2 the sequence derived from a brain library the sequence also remains open 5' to the suggested initiator codon, and is homologous to rat Dlgap2, it remains possible that in brain the translation of DLGAP2 is initiated at the earlier ATG than in other tissues. However, despite several attempts we were not able to isolate this longer brain DLGAP2 transcript. The total length of DLGAP2 cDNA sequence assembled is approximately 10 kb, 2928 bp of which is open reading frame in testis and 3062 bp in brain transcripts (Genbank AF119817 and AF119818). By northern analysis (MTN-1; Clontech) DLGAP2 was found to be expressed mainly in brain ( Figure 2) .
We established the genomic structure of DLGAP2 by sequencing genomic clones obtained from a plasmid library of BAC 156G21 using part of DLGAP2 as a probe, and from Table 1 . We found 12 coding exons that corresponded to the brain transcript (exons 2-13, Figure 1 ). The putative 103 bp of coding sequence as well as the 5' untranslated sequence are still missing from the brain cDNA sequence (see above). Exons 2 and 3 are alternatively spliced in testis, where the last 29 bp of exon 2 and the first 68 bp of exon 3 form the 5' untranslated region in addition to the 22 bp of sequence encoded by exon 1 (Figure 1) .
We then proceeded to screen the known coding regions and their immediately flanking intronic sequences in DLGAP2 for mutations by sequencing amplified genomic DNA from two patients and one control individual. The primers used for sequencing are shown in Table 2 . A homozygous silent substitution 1928G > A (both GAG and GAA coding for Glu) was found in exon 6 in the two patients. As an EPMR carrier was also found homozygous for this change it was considered a polymorphism. No other sequence differences between patients and the control were identified.
Based on sequence information obtained from GenBank (AC005010), marker 140CA is located between exons 2 and 3 of DLGAP2 (see Figure 1) . The region telomeric to 140CA has been previously excluded from harbouring the EPMR mutation on the basis of a recombination event that has occurred with 140CA and markers telomeric to it in one EPMR family. 5 Using a novel tetranucleotide marker, 85GGAA (GenBank Figure 2 The tissue expression pattern of DLGAP2 A Only a 10 kb brain-specific transcript is detected using a probe from the 3' untranslated region (nt 8059-8626; GenBank AF119817). B Using a probe from the coding region (nt 753-1790; GenBank AF119817) additional smaller brain transcripts, as well kidney transcripts of relatively weak intensity are detected suggesting either alternatively spliced forms of DLGAP2 or hybridisation to homologous DLGAP genes. The exon-intron boundaries of this non-coding exon were not determined. Table 2 Primers used to amplify the coding regions for mutation detection. Primers for exon 2 amplify both exon 2a and 2b sequences (see Table 1 )
Human DLGAP2 gene and its exclusion in EPMR S Ranta et al y acc. no AC005010; primers 5'-GGA TGC AAG GAT GGA AG-G AT-3' and 5'-CCA TCC ATC TTT AAG ACC CA-3') within the same intron as 140CA, some 7 kb centromeric to it (Figure 1 ), this recombination event was further refined between markers 140CA and 85GGAA (Figure 3) . Thus, based on the localisation of markers 140CA and 85GGAA in relation to DLGAP2 (Figure 1) , the region 5' to exon 3 of the DLGAP2 cDNA was excluded from containing the EPMR mutation. In this study we describe the characterisation of a novel gene, DLGAP2 localised in the EPMR critical region. Our results provide evidence that DLGAP2 is not the gene underlying EPMR, although as a brain gene interacting with ion channels through the PSD-95 protein DLGAP2 was initially considered a reasonable positional and functional candidate. 
